Watchmaker Genomics at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Watchmaker Genomics brings 3 presentations to AMP 2026 in Seattle, and exhibits at Booth 823, MR6. Its sessions cover amplification reagents for infectious disease assay development and sequencing that reads methylation. Another offers TAPS+ sequencing as an alternative to methylation arrays for classifying central nervous system tumors.

OrganizationAMP 2026 Attendance
Suppliers
Engineers and manufactures enzymes for reading, writing and editing DNA and RNA in genomics applications.
Booth
Exhibiting at Booth 823, MR6
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
2:00pm–2:50pm
From Reagents to Results: Enabling Infectious Disease Assay Development with Innovative Amplification Solutions
Enzyme and amplification chemistry choices that shape sensitivity, inhibitor tolerance and speed in infectious disease assay development.
Workshop
Wed, Nov 11
4:00pm–4:50pm
Beyond EPIC Arrays: TAPS+ Sequencing for Epignostix Heidelberg CNS Tumor Classification
Methylation sequencing as an alternative to arrays for classifying central nervous system tumors, with variant calling from the same assay.
Workshop
Fri, Nov 13
3:00pm–3:30pm
Beyond Methylation: Comprehensive Genomic Profiling from FFPE and Liquid Biopsy Samples
One assay reading both methylation and genomic variants from FFPE tissue and cell-free DNA in cancer research.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Watchmaker Genomics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction